文献速递肝病

病因不明的急性肝衰竭:专家委员会建立因果关系的综合系统方法

Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality.
PubMed 文献 · Am J Gastroenterol · 2018-06-27

美国急性肝衰竭研究组注册中约11%病例被当地主要研究者判为病因不明,该研究由6名资深审阅者制定病因特异性算法,对303例初判病因不明者复核,其中142例(46.9%)可重新归因于单一明确病因,最终真正病因不明者仅占5.5%。

要点

  • 对初判病因不明的急性肝衰竭病例,经专家委员会算法复核后近半数可明确病因。
  • 重新归因的病因包括既往未识别的对乙酰氨基酚、自身免疫性肝炎、药物性肝损伤等。
  • 复核后真正病因不明者仅占全部急性肝衰竭患者的5.5%。

核心结论

  • 急性肝衰竭的病因不明诊断中,部分患者经更仔细检查后病因是可辨识的;使用补充检测和专家意见修订病因诊断有助于理解急性肝衰竭的各个方面。

研究设计与样本

  • 由包括6名具有20年或以上经验的审阅者组成的因果裁定委员会制定每种病因的特异性算法,对2718例急性肝衰竭患者中303例初判病因不明者进行委员会复核。
  • 在可获得时检测血清中对乙酰氨基酚蛋白加合物,进行额外戊型肝炎病毒检测,并通过微阵列分析和宏基因组下一代测序寻找病毒序列。
  • 要求研究站点提供肝活检和/或 explant 报告,并更新先前未报告的血清学结果。

主要发现

  • 303例初判病因不明病例中,142例(46.9%)可重新归因于单一明确病因并评为高度可能或可能。
  • 另有11例经复核不符合急性肝衰竭标准。
  • 重新归因的病因中,45例为既往未识别的对乙酰氨基酚,34例为自身免疫性肝炎,24例为药物性肝损伤,13例为各种病毒原因,12例为缺血,14例为其他杂项病因。
  • 剩余150例被认定为真正病因不明,仅占5.5%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In the United States, the Acute Liver Failure Study Group (ALFSG) registry lists approximately 11% of cases as of indeterminate etiology (IND-ALF) as determined by the respective local site principal investigator (PI). Traditionally, IND-ALF has prompted concern that other viruses or toxins might be implicated. We hypothesized that many IND- ALF cases would have an identifiable etiology upon further investigation. Improving the identification process should reduce the number of truly indeterminate cases. METHODS: Specific definitions for each etiology ("etiology-specific algorithms") were developed by a Causality Adjudication Committee that included six reviewers (each with 20 or more years of experience). Of 2718 patients with ALF, 303 initially deemed IND-ALF by site PIs underwent committee review guided by the algorithms. Acetaminophen (APAP) protein adducts were measured in sera when available, additional HEV testing was performed, and viral sequences sought by microarray analysis and metagenomic next-generation sequencing (mNGS). Study sites were asked to provide liver biopsy and/or explant reports and to update serological findings not reported previously. RESULTS: Nearly half (142, 46.9%) of the 303 IND-ALF cases could be reassigned to a single, defined etiology and rated as highly likely or probable; 11 additional cases, upon review, did not meet ALF criteria. Amongst reassigned etiologies, 45 were previously unrecognized APAP, 34 autoimmune hepatitis (AIH), 24 drug-induced liver injury (DILI), 13 various viral causes, 12 ischemia, and 14 miscellaneous other etiologies. The remaining 150, deemed true IND-ALF, represented just 5.5%. CONCLUSIONS: The indeterminate etiology in ALF includes patients with a diagnosis that is discernible after closer examination. Revision of etiologic diagnoses of indeterminate cases using added testing and expert opinion is useful in understanding all aspects of ALF.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Ganger DR, Rule J, Rakela J, et al. Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality. Am J Gastroenterol. 2018. PMID: 29946176. doi:10.1038/s41395-018-0160-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。